# US 2017/0253924 A1 · Method for genomic profiling of dna 5-methylcytosine and 5-hydroxymethylcytosine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253924 A1
- Document ID: US20170253924A1
- Status: Published application
- Kind: A1
- Application number: 15/497,247
- Filed: 2017-04-26
- Published: 2017-09-07
- Earliest claimed: 2016-03-02
- Assignees: Shanghai Epican Genetech Co. Ltd
- Applicants: Shanghai Epican Genetech Co. Ltd
- Inventors: Xingyu Lu; Yanqun Song
- Web page: https://patentgrep.com/patent/US20170253924A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/68: involving nucleic acids
- C12Q 1/6827: for detection of mutation or polymorphism
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention provides a method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine, comprising the following steps: (1) DNA purification and fragmentation pretreatment: the target DNA is extracted and then broken to an average of 50 nucleotides to 10,000 nucleotides in length; (2) the repair of trace amount of DNA and the ligation thereof to the adaptor: the pre-treated DNA fragments are repaired and ligated with the sequencing adaptor required for the second-generation sequencing, (3) covalently labeling 5-methylcytosine and 5-hydroxymethylcytosine, (4) solid-phase enrichment of the labeled DNA fragments having cytosine with 5-position modification; (5) the PCR amplification of the solid-phase enriched DNA fragments, the PCR product is obtained and purified to obtain a library for the second-generation sequencing, after mapping the sequencing reads to the genome, the distribution map of the cytosine with 5-position modification in the DNA sample could be generated. The present invention greatly enhances the selectivity and efficiency of binding of the solid-phase surface with the DNA modified base.

## Claims

### Claim 1

A method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine, characterized in that, it comprises the following steps:
(1) DNA purification and fragmentation pretreatment:
the target DNA is extracted using a mechanical force or digestive enzyme to break it to an average of 50 nucleotides to 10,000 nucleotides in length;
(2) the repair of trace amount of DNA and the ligation thereof to the adaptor:
the pre-treated DNA fragments are repaired and ligated with the sequencing adaptor required for the second-generation sequencing;
(3) covalently labeling 5-methylcytosine and 5-hydroxymethylcytosine:
cytosine with 5-position modification in the DNA fragment to which the adaptor is ligated is covalently labeled;
(4) solid-phase enrichment of the labeled DNA fragment having cytosine with 5-position modification:
the labeled DNA fragment having cytosine with 5-position modification is bound to the solid phase in the binding buffer, and the solid phase surface is repeatedly washed, to remove the unbound DNA fragment;
(5) the PCR amplification primers corresponding to the adaptor are used to carry out an amplification of the solid-phase enriched DNA fragments, the PCR product is obtained and purified to obtain a library for the second-generation sequencing, after mapping the sequencing reads to the genome, the distribution map of the cytosine with 5-position modification in the DNA sample could be generated.

### Claim 2 (depends on 1)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 1, characterized in that,
wherein, in step (1), the DNA fragment is derived from the free DNA fragments in a body fluid, or genomic DNA purified from tissues, cells and organelles.

### Claim 3 (depends on 2)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 2, characterized in that,
in step (1) the body fluid of DNA fragment is derived from blood, urine, sweat, sputum, feces, cerebrospinal fluid, ascites, pleural effusion, bile, pancreatic fluid.

### Claim 4 (depends on 1)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethyleytosine according to claim 1, characterized in that,
wherein, the DNA fragment repair in the step (2) is a step of repairing base damage in DNA fragment, and 5’ and 3′ of DNA are made up to a blunt-end.

### Claim 5 (depends on 1)

The method for genornic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 1, characterized in that,
in step (3), the method of labeling, comprises the steps of: i) an azide-group modified sugar is covalently linked to the hydroxymethl group of 5-hydroxymethylcytosine using transglycosidase, ii) azido sugar-modified 5-hydroxymethylcytosine reacts with click-chemistry substrate linked directly or indirectly to a biotin.

### Claim 6 (depends on 5)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 5, characterized in that
the Transglycosylase includes, but is not limited to, bGT, aGT and its derivatives, analogs or recombinant enzymes; azide-group modified sugars include, but are not limited to, 6-N3-glucose or other azido-modified sugar.

### Claim 7 (depends on 5)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 5, characterized in that,
labeling methylcytosine includes the steps of i) 5-methylcytosine oxidized to 5-hydroxymethylcytosine using murine Tet oxidase or a derivative thereof, analogues, recombinant enzymes, biotin labeling of 5-hydroxymethylcytosine is carried out as described above.

### Claim 8 (depends on 1)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 1, characterized in that,
wherein, labeling steps of 5-hydroxymethylcytosine can be carried out in sequence or simultaneously in a reaction.

### Claim 9 (depends on 1)

The method for genomic profiling of DNA 5-methylcytosine and 5-hydroxymethylcytosine according to claim 1, characterized in that,
wherein, in step (4), the solid phase material includes a magnetic ball having a diameter of 1 nm to 100 μm, agarose beads of 1 nm to 100 μm in diameter, artificial macromolecule balls with diameters of 1 nm to 100 μm, silicon wafers with surface modification or other biochips.

### Claim 10 (depends on 1)

The sequencing method of DNA 5-methylcytosine and 5-hydroxy methylcytosine according to claim 1, characterized in that,
in step (5), the qualified sequencing library is obtained by amplification of 1-40 PCR cycles on the solid phase directly, or after the amplification by 1-40 PCR cycles the solid-liquid phase is separated and then the qualified sequencing library is obtained by further amplification of 1 to 40 PCR cycles.
